Volver a Agenda
Session 4, Track C: Pharmacovigilance Unleashed: Unlocking PV Best Practices through KPIs and Data Mining
Session Chair(s)
Mei Lam, BSN, RN
Associate Director Consumer Safety Regions Americas, Haleon, Canada
Vanessa Zapata
Associate Director, Regional Pharmacovigilance Officer, Merck Canada Inc., Canada
This game-changing session will unravel the secrets of effective key performance indicators (KPIs) and their powerful application in the realm of pharmacovigilance. Industry experts will provide a deep dive into innovative solutions that seamlessly support pharmacovigilance integration activities during company acquisitions and product in-licensing deal. Additionally, the session offers exclusive insights from a health agency perspective on KPIs, providing a comprehensive understanding of this critical aspect of pharmacovigilance.
Learning Objective : - Analyze the critical role of Key Performance Indicators (KPIs) in optimizing pharmacovigilance processes
-
Demonstrate the application of data mining techniques to uncover valuable insights and drive informed decision-making in pharmacovigilance activities
- Evaluate strategies for seamlessly integrating pharmacovigilance operations during company acquisitions and product in-licensing deals, aligning with industry best practices
Speaker(s)
Stephanie Stankiewicz, MBA
Director, Drug Safety, Merck Sharp & Dohme LLC, United States
Innovative Solutions to Support PV Integration Activities in Company Acquisitions and Product In-license Deals
Manar Hammood, MSC
Founder and Director of PV Operations, Zenith PV, Canada
Effective KPIs and their application in PV
Fadi Sader, PHD
Regional Regulatory Compliance and Enforcement Officer, Health Canada, Canada
Expedited Reporting Compliance – A Health Canada Inspector’s Perspective
¿Tiene una cuenta?